The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: modifications to the androgen receptor

被引：99

作者：

Edwards, J ^{[1
]}

Bartlett, JMS ^{[1
]}

机构：

[1] Univ Glasgow, Glasgow Royal Infirm, Endocrine Canc Grp, Sect Surg & Translat Res,Div Canc & Mol Pathol, Glasgow G31 2ER, Lanark, Scotland

来源：

BJU INTERNATIONAL | 2005年 / 95卷 / 09期

关键词：

androgen receptor; hormone resistance; MAP kinase; PI3K and PKC;

D O I：

10.1111/j.1464-410X.2005.05526.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1320 / 1326

页数：7

共 36 条

[31]

Thakkar H, 2002, J BIOL CHEM, V277, P30408

[32] Androgen receptor mutations in high-grade prostate cancer before hormonal therapy [J].

Thompson, J ;

Hyytinen, ER ;

Haapala, K ;

Rantala, I ;

Helin, HJ ;

Jänne, OA ;

Palvimo, JJ ;

Koivisto, PA .

LABORATORY INVESTIGATION, 2003, 83 (12) :1709-1713

[33] Looking to the future: Advances in the management of hormone-refractory prostate cancer [J].

Trachtenberg, J ;

Blackledge, G .

EUROPEAN UROLOGY SUPPLEMENTS, 2002, 1 (07) :44-53

[34] Differential expression and/or activation of P38MAPK, Erkl/2, and Jnk during the initiation and progression of prostate cancer [J].

Uzgare, AR ;

Kaplan, PJ ;

Greenberg, NM .

PROSTATE, 2003, 55 (02) :128-139

[35]

Wallén MJ, 1999, J PATHOL, V189, P559

[36] Identification of a novel phosphorylation site in human androgen receptor by mass spectrometry [J].

Zhu, ZX ;

Becklin, RR ;

Desiderio, DM ;

Dalton, JT .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 284 (03) :836-844

← 1 2 3 4 →